Non-Muscle-invasive Bladder Cancer (NMIBC) Recruiting Phase 1 Trials for Paclitaxel (DB01229)

Also known as: Non-Muscle- Invasive Bladder Cancer / NMIBC / Non-muscle Invasive Bladder Cancer / Non Muscle-invasive Bladder Cancer / Non-muscle-invasive Bladder Cancer / Non-muscle Invasive Bladder Cancer (NMIBC) / Non Muscle Invasive Bladder Cancer / Nonmuscle Invasive Bladder Cancer / Non-Muscle Invasive Bladder Neoplasms / Carcinoma of urinary bladder, superficial (disorder) / Urothelial carcinoma bladder / Bladder transitional cell carcinoma / Transitional cell carcinoma of bladder (disorder)

IndicationStatusPhase
DBCOND0082324 (Non-Muscle-invasive Bladder Cancer (NMIBC))Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05519241
A Phase I Intravesical PPM Therapy for NMIBCTreatment